CLINICAL_TRIALS
trial_result
· 2019-11-27
Clinical Trial Update: Lasmiditan Compared to Placebo in the Acute Treatment of Migraine: [Phase 3]
Summary
Phase 3 clinical trial comparing lasmiditan to placebo for acute treatment of migraine has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Acute Migraine | Phase 3 | Status: COMPLETED | Results posted: 2019-11-27